All News

Further, they found weight loss prior to 75-g oral glucose tolerance test was a preventive factor for both impaired glucose tolerance and diabetes.

Amgen launches AmgenNow, which is a new direct-to-patient program that will start with evolucumab.

As the sixth approval for roflumilast in less than 4 years, the cream is expected to impact the 1.8 million children who have reported atopic dermatitis.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses the opportunities incorporating pharmacy technology can create for pharmacies and their businesses.

Don Roosan, PharmD, PhD, discusses the ethical implications of AI in pharmacy, focusing on patient safety, transparency, and the importance of human connection in care.

Don Roosan, PharmD, PhD, discusses the changing technology, challenging conventional boundaries of pharmaceutical practice through telepharmacy and artificial intelligence.

Researchers conduct a pilot study that assesses clinical pharmacists’ interventions and management of chronic diseases for older adults living in senior housing facilities.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Hannah Fish, PharmD, CPHQ, about the NCPA’s maternal immunizations tool kit and pharmacist support for mothers.

Prior to the government shutdown, the FDA approved a generic version of mifeprisone without a public announcement.

Significant patient reports show a lack of response to treatment for community-acquired pneumonia, leading researchers to investigate the use of corticosteroids.

Ashley Moose, PharmD, owner of Moose Pharmacy of Monroe and director of network development at CPESN USA, capped off this fall’s event and discussed where to access sessions on demand.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss their use of the PRISM platform for providing contraceptive and family-planning services.

This is the first Bruton tyrosine kinase inhibitor FDA approved for chronic spontaneous urticaria.

This month, Drug Topics® explores a new avenue of pharmacy each week, including AI technology, student education, innovative community services, and the expansion of clinical care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Shane Desselle, RPh, PhD, FAPhA, professor of Pharmacy Practice and Social Pharmacy at Touro University California.

Amid ongoing approaches to lower drug prices for US patients, like the Most-Favored-Nation policy, this is another partnership the Trump Administration believes will improve access challenges.

In part 2 of our interview, Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss the evolution of contraceptive services and how pharmacy is supporting rural communities and their patients.

In part 3 of our interview with Bill Wolfe, COO of WriteWise, he discusses the technology backing his team’s approach to forever changing how pharmacy benefits are distributed in the US.

Since 2016, the rate of gabapentin prescribing slowed but is still increasing, especially for women and older adults.

This marks the first and only IL-23 approval for these indications in pediatric populations.

Amid recent measles outbreaks in Texas and Ohio, researchers aim to understand MMR vaccine coverage following postelimination outbreaks throughout the country.

Lissette Logan, PharmD, COO at OvaryIt, joined Drug Topics to discuss the fragmentation of contraceptive care in the US and how pharmacists are uniquely positioned to provide these services.

Based on a new report detailing the current trends in PBM types from the Big 3 to new grassroots organizations, Bill Wolfe, COO of WriteWise, discusses a shifting pharmacy benefits landscape.

Researchers address impacts of the Inflation Reduction Act on the access, cost, and coverage of glucagon-like peptide-1 medications for patients with diabetes.

In the final part of our interview with Mark Garofoli, PharmD, BCGP, CPE, CTTS, he discusses what the future will hold regarding clinical decision-making following the reported acetaminophen-autism link.

Pharmacists are on the front line for patients looking to self-manage their menstrual pain, making their role invaluable in women’s health.

Pain medication expert Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to explore the referenced studies in the Trump Administration’s push to link acetaminophen use with autism.